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Na/K-ATPase plays an important role in 
mediating blastocyst formation. Despite the 
expression of multiple Na/K-ATPase α and β 
isoforms during mouse preimplantation 
development, only the α1 and β1 isoforms have 
been localized to the basolateral membrane 
regions of the trophectoderm. The aim of the 
present study was to selectively down-regulate 
the Na/K-ATPase β1 subunit employing 
microinjection of mouse 1 cell zygotes with 
small interfering RNA (siRNA) oligos. 
Experiments comprised of non-injected 
controls and two groups microinjected with 
either StealthTM Na/K-ATPase β1 subunit oligos 
or non-specific StealthTM  siRNA as control. 
Development to the 2-, 4-, 8-, 16-cell and 
morula stages did not vary between the three 
groups. However, only 2.3% of the embryos 
microinjected with Na/K-ATPase β1 subunit 
siRNA oligos developed to the blastocyst stage 
as compared to 73% for control injected and 
91% for non-injected controls. Na/K-ATPase 
β1 subunit down regulation was validated by 
employing RT-PCR and whole-mount 
immunofluorescence methods to demonstrate 
that Na/K-ATPase β1 subunit mRNAs and 
protein were not detectable in β1 subunit 
siRNA microinjected embryos. Aggregation 
chimera experiments between β1 subunit 
siRNA microinjected embryos and controls 
demonstrated that blockade of blastocyst 
formation was reversible. The distribution of 
Na/K-ATPase α1 and tight junction associated 
proteins Occludin and ZO-1 were compared 
among the three treatment groups. No 
differences in protein distribution were 
observed between control groups however, all 
three polypeptides displayed an aberrant 
distribution in Na/K-ATPase β1 subunit siRNA 
microinjected embryos. Our results 
demonstrate that the β1 subunit of the Na/K-
ATPase is required for blastocyst formation 
and that this subunit is also required to 
maintain a normal Na/K-ATPase distribution 
and localization of tight junction associated 
polypeptides during preimplantation 
development. 
 
Research investigating the mechanisms 
directing blastocyst formation has demonstrated 
that: a) the Na/K-ATPase assumes a polarized 
distribution confined to the trophectoderm 
basolateral membrane regions just prior to the 
onset of cavitation (1,2); b) expression of Na/K-
ATPase subunit genes are up-regulated during the 
morula to blastocyst transition (3-7); c) that Na/K-
ATPase activity is significantly increased during 
the morula to blastocyst transition for a number of 
mammalian species (2,8-10); d) that treatment 
with ouabain (a potent and specific inhibitor of the 
Na/K-ATPase) affects cavitation and blastocyst 
formation in a number of mammalian species 
(5,11-15);  e) that deletion of the Na/K-ATPase α1 
subunit gene product is linked to aberrant 
blastocyst formation in vitro and likely peri-
implantation lethality in vivo (16); and f) that 
Na/K-ATPase also regulates the formation and 
function of trophectoderm tight junctions (17).  
Taken together, these data support the 
hypothesis that the Na/K-ATPase contributes 
directly to the mechanism that regulates fluid 
movement across the trophectoderm resulting in 
the formation of the fluid-filled blastocoelic 
cavity. Our most recent efforts have initiated 
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studies to investigate the individual roles of each 
Na/K-ATPase subunit during preimplantation 
development (16) and to explore whether the Na+-
pump also regulates tight junction formation and 
function during blastocyst formation (17). Much to 
our initial surprise we discovered that it was 
possible to collect quite normal looking day 3.5 
post-hCG Na/K-ATPase α1 null blastocysts from 
the reproductive tracts of heterozygous mice (16).  
However these α1 null embryos struggle to attach 
and form trophoblast outgrowths in culture and do 
not form fully expanded blastocysts if collected 
and placed into culture at the 8-cell stage for 
determination of their developmental potential 
(16).  Therefore we have concluded that the α1 
subunit of the Na/K-ATPase is required for normal 
development and initiation of pregnancy and that 
limited compensation perhaps by an alternative 
Na/K-ATPase α subunit isoform is able to allow 
for short term development of α1 null embryos to 
the blastocyst stage in vivo.   
In the continuation of our pursuit of an 
understanding of the roles of each Na/K-ATPase 
subunit during preimplantation development, we 
have conducted the present study to characterize 
the consequences to early development and 
blastocyst and tight junction formation following 
the selective down-regulation of the Na/K-ATPase 
β1 subunit by employing microinjection of 1 cell 
mouse zygotes with small interfering RNA 
(siRNA) oligos. Our results demonstrate that the 
β1 subunit of the Na/K-ATPase is required for 
blastocyst formation and that this subunit is 
required to maintain a normal Na/K-ATPase 
distribution and localization of tight junction 
associated polypeptides during preimplantation 
development. 
 
Experimental Procedures 
 
Super-ovulation and embryo collection - 
Female CD-1 mice (Charles River, Canada), 
4-5 weeks of age, were injected with 10 IU of 
PMSG (pregnant mare’s serum 
gonadotrophin; Intervet, Whitby, Canada), 
followed by 10 IU of hCG (human chorionic 
gonadotropin; Intervet, Whitby, Canada) 48 h 
later and just before mating with CD-1 males. 
Successful mating was determined the next 
morning by the presence of a vaginal plug and 
was considered day 0.5 of development. One-
cell stage embryos were flushed from oviducts 
of female mice using flushing medium I (1.71 
mM calcium lactate, 0.25 mM sodium 
pyruvate, 3 mg/ml BSA and 10x Leibovitz-
modified Hanks balanced salt solution, all 
diluted with water to 1x) (Spindle, 1980) 
containing hyaluronidase (1 mg/ml, Sigma, St 
Louis, Mo.).  The embryos were washed 3x in 
potassium simplex optimized medium 
(KSOM) media  (Summers et al., 1995) under 
paraffin oil in sterile culture dishes and 
subsequently cultured in KSOM medium plus 
amino acids (KSOMaa) (Summers et al., 
1995) under a 5% CO2 in air atmosphere at 
37oC until transferred into experimental 
treatment groups as defined below. All 
medium components were purchased from 
Sigma unless stated otherwise. KSOMaa 
medium was made fresh before each 
collection and was sterile filtered. The 
osmolarity of the medium was tested each 
time it was prepared and ranged between 288-
298 mOsm. All experiments described in this 
study, maintained a treatment drop volume to 
embryo ratio of one embryo per µl of 
KSOMaa culture medium. Animal care and 
handling was according to the guidelines of 
the University of Western Ontario Animal 
Care Committee. 
Microinjection of siRNAs - Microinjection was 
performed under an inverted microscope using 
a mechanical micromanipulator (Leica) 
attached to Picoinjector PLI-100 (Harvard 
Apparatus, Saint-Laurent, Quebec, CA). Each 
injection delivered 10 pl of 20 μM siRNA 
duplexes into the cytoplasm of one-cell stage 
embryos. Microinjection of embryos was 
performed according to a standard procedure. 
One cell embryos were placed in KSOMaa 
medium under light mineral oil. A holding 
pipette (Conception Technologies, Colorado, 
USA) was used to keep the 1-cell embryos 
stationary during manipulation. An injection 
pipette (Conception Technologies, Colorado, 
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USA) loaded with dsRNA solution was 
inserted into the cytoplasm of each zygote 
followed by the microinjection of ~10 pl 
dsRNA. After microinjection, embryos were 
cultured in KSOMaa medium as described 
above for up to 4 days to allow for an 
assessment of developmental capacity to the 
blastocyst stage. About 300 embryos were 
used for each experimental replicate and in 
total a set of three replicates were conducted. 
RNA extraction, reverse transcription and 
polymerase chain reaction (RT-PCR) - Total 
RNA was extracted from murine embryos 
(pools of 20 embryos/stage at 1-, 2-, 4-, 8-cell, 
morula and blastocyst stages) using the phenol 
chloroform method of Chomczynski and 
Sacchi (18). The total RNA extracts were 
digested with deoxyribonuclease (DNAse)-1 
to eliminate possible contamination from 
genomic DNA. The reverse transcription (RT) 
reactions were conducted using oligo-dT 
primers (Gibco BRL) as previously described 
(19,20). Briefly, samples were incubated for 
90 min at 42oC in a total volume of 20 μl 
consisting of 50mM Tris-HCl (pH 8.3), 75 
mM KCl, 3 mM MgCl2, 10 mM DTT, 0.5 mM 
dNTPs, and 200 units of Superscript II 
(Invitrogen, Mississauga, Ontario) followed 
by heating the samples to 95oC for 5 min for 
termination of reaction. 
Polymerase chain reaction (PCR) was 
conducted using a previously described 
protocol (21). Briefly, two embryo equivalents 
for each stage of development under 
investigation were used per PCR reaction, 
which was repeated a minimum of three times 
from pools of three different developmental 
series of embryos. The conditions for each 
PCR reaction are given in Table 1. PCR 
products were resolved on 2.0% agarose gels 
containing 0.5 μg/ml ethidium bromide 
(Invitrogen, Burlington, ON). To confirm the 
specificity of each PCR product, 
representative amplicons were extracted from 
the gels and purified using a QIAquick Gel 
Extraction Kit (Qiagen, Mississauga, ON) and 
submitted for nucleotide sequencing (DNA 
Sequencing Facility, Robarts Research 
Institute, London, ON, Canada). The 
nucleotide sequence was subsequently 
compared to sequences available in GenBank 
nucleotide sequence database and in all cases 
the specificity of each PCR product was 
confirmed. There was 98% sequence identity 
to mouse Na/K-ATPase β1 subunit sequence. 
Embryo fixation and whole-mount indirect 
immunofluorescence - To analyze the 
distribution of Na/K-ATPase α and β 
isoforms, ZO-1 and Occludin polypeptides 
during murine preimplantation development, a 
whole-mount immunofluorescence method 
previously described (21) was employed. 
Immunofluorescence was detected using laser 
scanning confocal microscopy as described 
(19). Briefly, embryos at timed stages of 
development (1-cell zygotes, 2-,4-,8-cell, 
morula and blastocyst stages) were washed in 
1X phosphate buffer saline (PBS) and then 
fixed in 2% paraformaldehyde (PFA) in PBS 
for 20 min at room temperature. These fixed 
embryos were washed in 1X PBS and either 
processed immediately for immuno-staining 
or stored at 4oC in PBS + PHEM for a 
maximum of 4 weeks. 
For immuno-staining, fixed embryos 
were permeabilized and blocked in 1X PBS + 
5% Donkey Serum + 0.01% Triton X-100 for 
1 hour at room temperature. Embryos were 
washed in 1X PBS and incubated with 
primary antibody diluted 1:100 in 1X PBS 
+1% Donkey Serum + 0.005% Triton X-100 
for one hour at room temperature followed by 
additional washes totaling 1 hour at 37oC. 
Primary antibodies were labeled by incubation 
for one hour with fluorescein isothiocyanate 
(FITC)-conjugated secondary antibodies 
(Jackson Immuno Labs, MA, USA) diluted 
1:200. Embryos were then treated with 
rhodamine-conjugated phalloidin (5μg/ml; 
1:20) and 4,6-diamidino-2-phenyl-indole 
(DAPI) (1mg/ml; 1:2000) for 30 minutes at 
37oC followed by 2 washes for 2 hours each at 
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37oC. Embryos were mounted in Fluoro-
Guard Antifade Mounting Reagent (BioRad, 
Mississauga, ON, Canada). Fluorescence 
patterns were examined using a Zeiss LSM 
410 (laser scanning microscope) with an 
inverted Axiovert 100 microscope under 20-
40X magnification. The images were then 
captured and stored as TIFF files by the Zeiss 
LSM software package. 
Primary antibodies for Na/K-ATPase 
α and β subunits and Z0-1 were obtained from 
Upstate Cell Signaling Solutions, 
Charlottesville, VA. Primary antibody for 
Occludin was obtained from Zymed, San 
Francisco, CA. 
siRNA oligo preparation - Double stranded 
siRNA oligos were designed using BLOCK-
iT™ RNAi Designer software (Invitrogen, 
Mississauga, ON). Stealth small interfering 
RNA (siRNA) duplex oligoribonucleotides 
against β1 subunit of Na/K-ATPase (GenBank 
Accession no: NM_009721) were synthesized 
by Invitrogen. The sequences were as follows: 
(i) sense 5'- CCC AAG AAU GAA UCC 
UUG GAG ACU U-3', antisense 5'- AAG 
UCU CCA AGG AUU CAU UCU UGG G-3'; 
(ii) Control sense 5'- CCC AAG AGU CUA 
UUC AGG AGA ACU U -3', antisense 5' 
AAG UUC UCC UGA AUA GAC UCU 
UGG G-3'. The duplex oligoribonucleotides 
were re-suspended in DEPC-treated water to 
make a 20 µM solution and stored at -20oC till 
further use. 
Reversal of developmental blockade by 
aggregation chimeras – Embryos from the 
three treatment groups (β1 subunit siRNA 
microinjected, random sequence siRNA 
injected control and non-injected control) 
were collected at the non-compacted 8-cell 
stage. These embryos were treated with acid 
Tyrode’s solution (pH 2.5) to remove zona 
pellucida. Denuded 8-cell embryos were 
washed 3 times in fresh KSOMaa drops and 
aggregated together for chimera production. 
The β1 subunit siRNA microinjected embryos 
were either paired with self like (A:A) or with 
uninjected controls (A:C) or random sequence 
siRNA injected controls (A:B). In addition, 
injected controls were also paired together 
(B:B) to serve as additional control. In total, 
76 chimeras were produced from 152 embryos 
over three replicates. Development of each 
aggregation chimera combination to the 
blastocyst stage was assessed. In addition 
chimeras from each group were processed for 
immunofluorescence localization of Na/K-
ATPase β subunit polypeptides as described. 
Statistical analysis - The results are presented 
as the means + S. E. M. from three 
independent experiments. Statistical 
differences between time points were assessed 
by analysis of variance (ANOVA). 
Differences were considered significant when 
p< 0.05. Significant differences between the 
means were determined using the least-
significant-difference test. 
 
RESULTS 
 
To investigate the consequences of 
Na/K-ATPase β1 subunit down regulation on 
preimplantation development we employed 
microinjection of β1 siRNAs into 1-cell 
zygotes. Our control groups consisted of non-
injected zygotes and those injected with a 
random sequence siRNA. In total over 300 
zygotes were placed into each treatment group 
for evaluation of developmental outcomes. 
The experiment was repeated 3 times using 
zygotes collected from different mouse 
populations each time. The morphology of 
zygotes in each group four days after injection 
is displayed in (Figure 1A). Zygotes injected 
with the Na/K-ATPase β1 siRNA developed 
through to the morula stage (Figure 1Aa and 
B). In contrast zygotes injected with control 
siRNA or non-injected controls displayed a 
high frequency of development through to the 
blastocyst stage after injection (Figure 1Ab 
and c). In both injected groups we observed a 
nearly equal number of zygotes that did not 
develop likely due to damage caused by the 
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microinjection procedure (Figure 1Aa and b). 
When the data was plotted and analyzed we 
clearly observed that injection with the Na/K-
ATPase β1 subunit siRNA resulted in a 
significant reduction in the proportion of 
zygotes that completed development to the 
blastocyst stage (Figure 1B). Control injected 
and control non-injected zygotes displayed a 
comparable blastocyst developmental 
frequency (Figure 1B). The majority of β1 
siRNA injected zygotes attained and then 
remained at the morula stage 4 days after 
injection (Figure 1B). Attempts to provide 
morulae in the Na/K-ATPase β1 siRNA 
treatment with additional time to progress 
beyond the morula stage by extending their 
culture interval for an additional 24 hours did 
not increase the develop of embryos in this 
group to the blastocyst stage (data not shown).    
 To ensure that the Na/K-ATPase β1 
siRNAs we employed were effective at down 
regulating Na/K-ATPase β1 gene expression 
during early development we applied RT-PCR 
methods to detect Na/K-ATPase β1 mRNAs 
and also whole mount immunofluorescence 
methods to map out Na/K-ATPase β1 protein 
distribution. It was readily possible to detect 
transcripts encoding the Na/K-ATPase β1 
subunit in control injected and non-injected 
control groups as indicated by the appearance 
of an expected size RT-PCR product in 
samples from both groups (Figure 1C). In 
contrast it was not possible to detect the Na/K-
ATPase β1 RT-PCR product in samples 
prepared from Na/K-ATPase β1 siRNA 
injected zygotes (Figure 1C). To ensure that 
Na/K-ATPase β1 siRNA prepared samples 
still retained intact RNA, we employed RT-
PCR to amplify transcripts encoding β-actin. 
In all samples from all treatment groups it was 
readily possible to detect the expected size β-
actin cDNA product. The application of 
whole-mount immunofluorescence methods 
employing a Na/K-ATPase β1 subunit specific 
antiserum revealed a complete absence of 
detectable Na/K-ATPase β1 subunit protein in 
β1 siRNA injected zygotes (Figure 2 a,b,c). In 
contrast the Na/K-ATPase β1 subunit was 
detected in both control injected and non-
injected controls beginning at the 8-16 cell 
stage and also in both morulae and blastocyst 
stages as reported earlier (Figure 2 e,f,g,h,; 
(7)). In control blastocysts the Na/K-ATPase 
β1 subunit immunofluorescence maintained 
the expected polarized distribution in the 
trophectoderm and an apolar distribution in 
the inner cell mass (Figure 2h). When we 
examined the few blastocysts that formed in 
the Na/K-ATPase β1 siRNA injected 
treatment group, no organized Na/K-ATPase 
β1 subunit protein distribution could be 
detected (Figure 2d), instead a few small 
indistinct patches of green fluorescence were 
observed in these embryos (Figure 2d). In 
total, these outcomes demonstrate that the 
Na/K-ATPase β1 siRNA we employed in this 
study effectively down regulated Na/K-
ATPase β1 subunit expression for at least 5 
days during mouse preimplantation 
development.  
 We investigated the reversibility of the 
developmental blockade displayed by β1 
subunit siRNA microinjected embryos by 
aggregating together 8-cell embryos from all 
three treatment groups to measure chimera 
formation and progression to the blastocyst 
stage. The β1 subunit siRNA microinjected 
embryos (Figure 4 A:A; Panel A) did not 
progress to the blastocyst stage. In contrast, β1 
subunit siRNA microinjected embryos which 
were paired with either random sequence 
siRNA microinjected (A:B), uninjected 
controls (A:C) or even injected controls paired 
together (B:B) all displayed a normal 
progression to the blastocyst stage (Figure 4 
Panel A). In addition localization of Na/K-
ATPase β subunit polypeptides in these 
chimeras by the application of 
immunofluorescence methods confirmed the 
complete absence of β subunit 
immunofluorescence in A:A (β subunit siRNA 
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injected) pairs (Figure 5a), normal β subunit 
immunofluorescence  in B:B pairs (Figure 5c) 
and reduced but obvious β subunit 
immunofluorescence in A:B pairs (Figure 
5i).We would conclude that development of 
the A:B and A:C chimeras to the blastocyst 
stage (Figure 4) was achieved by expression 
of  Na/K-ATPase β subunits by cells derived 
from the B or C embryo. This experiment 
therefore supports our initial conclusion that 
Na/K-ATPase β subunit expression is required 
for progression to the blastocyst stage. 
These studies clearly indicated that 
down regulation of Na/K-ATPase β1 subunit 
expression resulted in a blockade of blastocyst 
formation. To begin to define the Na/K-
ATPase β1 subunit’s role in mediating 
blastocyst formation, we investigated the 
effects of β1 subunit down regulation on the 
distribution of Na/K-ATPase α1 polypeptides 
and tight junction associated polypeptides, 
Occludin and ZO-1, since these polypeptides 
are among the best characterized markers of 
trophectoderm differentiation and blastocyst 
formation. We confined our analysis to morula 
stage embryos since it was not possible to 
generate blastocysts following microinjection 
of Na/K-ATPase β1 subunit siRNAs. In 
control injected and also control non-injected 
morulae we observed normal patterns of 
Na/K-ATPase α and ZO-1 and Occludin 
protein distribution (Figure 3 b,d,f). For Na/K-
ATPase α1  protein the fluorescence extended 
in an apolar fashion surrounding each morula 
blastomere (Figure 3b). Likewise both ZO-1 
and Occludin fluorescence maintained a tight 
cortical pattern surrounding the apical regions 
of each blastomere (Figure 3 d, f). In complete 
contrast Na/K-ATPase β1 siRNA injected 
morulae displayed a very aberrant Na/K-
ATPase α1 fluorescence pattern in which the 
fluorescence became “discontinuous” around 
each cell periphery, consisting more of a 
general cytoplasmic distribution rather than a 
cortical distribution (Figure 3a). The impact 
on ZO-1 and Occludin protein distribution 
was even more dramatic and the fluorescence 
pattern for both of these tight junction 
associated proteins became very diffuse and 
cytoplasmic in nature (Figure 3 c, e). Injection 
of Na/K-ATPase β1 siRNAs resulted in a 
complete loss of the tight “continuous” 
cortical distribution that is so typical for both 
ZO-1 and Occludin protein distributions in 
developing epithelia such as the 
trophectoderm. 
 
DISCUSSION 
 
Our results demonstrate that the Na/K-ATPase 
β1 subunit protein is required for blastocyst 
formation. In addition, our results indicate that 
the Na/K-ATPase β1 subunit oversees the 
proper localization of Na/K-ATPase α1 
subunit to the cortical membrane regions of 
each blastomere and also the proper 
distribution and assembly of tight junction 
associated polypeptides (ZO-1 and Occludin) 
to the apical membrane regions between 
differentiating trophectoderm cells. 
Interestingly, our results do not however 
indicate that the Na/K-ATPase β1 subunit is 
required to support early development to the 
morula (16-32 cell) stage of mouse 
development. We conclude that the Na/K-
ATPase β1 subunit is instrumental in 
coordinating the proper insertion of Na/K-
ATPase α/β subunits to appropriate 
membrane domains and also the formation 
and establishment of trophectoderm tight 
junctions. Thus the Na/K-ATPase β1 subunit 
is an important mediator of cell polarity, 
trophectoderm differentiation and blastocyst 
formation during mouse preimplantation 
development.   
 The Na/K-ATPase β subunit has been 
generally prescribed to serve two primary 
roles including; 1) a chaperone role that 
directs the insertion of the α subunit and 
functional enzyme unit to the appropriate 
membrane domain (22-25); and 2) the 
regulation of cation sensitivity of the Na/K-
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ATPase (26-28). Most recently however, an 
additional role in regulating epithelial cell 
phenotype and cell motility has been defined 
for the Na/K-ATPase β subunit (29-35). We 
would suggest that the results from our study 
support the likelihood that the Na/K-ATPase 
β1 subunit contributes to all three roles during 
blastocyst formation in the mouse.  
 Our results certainly indicate that we 
were able to specifically down regulate Na/K-
ATPase β1 subunit expression by the 
microinjection of β1 subunit specific siRNAs 
as we were unable to detect the presence of 
either Na/K-ATPase β1 subunit mRNAs or 
polypeptides in β1 subunit siRNA 
microinjected zygotes. This result coupled 
with the aberrant Na/K-ATPase α1 subunit 
distribution that we observed in the Na/K-
ATPase β1 subunit siRNA microinjected 
embryos has lead us to conclude that the 
Na/K-ATPase β1 subunit is required to direct 
the proper targeting and insertion of the Na/K-
ATPase α1 subunit into the trophectoderm 
cell membranes and without this occurring 
blastocyst formation is blocked.  
 But how might the Na/K-ATPase β1 
subunit microinjected zygotes survive to the 
morula stage? We have known for some time 
that the Na/K-ATPase β1 subunit gene 
products display a very dramatic upregulation 
just prior to blastocyst formation suggesting 
that the upregulation of this gene is required 
for cavitation to occur (3-5). Na/K-ATPase α 
subunit mRNAs are present throughout 
preimplantation development and display a 
much more gradual increase as the embryo 
progresses to the blastocyst stage (3-5). It is 
very likely that Na/K-ATPase α subunits 
outnumber β subunits by a wide margin in 
early embryo stages and thus the full 
upregulation of the Na/K-ATPase required to 
support cavitation cannot occur until Na/K-
ATPase β1 subunits increase to more closely 
match α subunit levels (3-5). As well mRNAs 
and polypeptides encoding the other Na/K-
ATPase β subunits (β2, β3) are also present in 
preimplantation embryos (5,7). We would 
suggest that the “housekeeping” and early 
cleavage stage (1-cell to morula) requirements 
for the Na/K-ATPase may be handled by 
primarily α1/β2 or α1/β3 isoenzymes but that 
at the morula stage the upregulation of Na/K-
ATPase β1 subunit gene products provides for 
the overall increase in enzyme (α1/β1 
isozymes) that is required to drive blastocyst 
formation. Alternatively despite not detecting 
mRNAs and polypeptides encoding the Na/K-
ATPase β1 subunit within β1 subunit siRNA 
microinjected embryos there may still be 
sufficient protein present that is below the 
level of immunofluorescence detection but is 
sufficient to pair up with Na/K-ATPase α1 
subunits to satisfy the “housekeeping” 
requirement of the enzyme up to the morula 
stage. Our results clearly indicate that the 
Na/K-ATPase β1 subunit is required to 
support blastocyst formation and proper 
insertion of Na/K-ATPase α1 subunits into 
trophectoderm membranes.  
 We have employed the 8-cell 
aggregation chimera method (36) to 
investigate the reversibility of the 
developmental blockade produced by the loss 
of Na/K-ATPase β1 subunit embryos and 
confirm the presence of β subunit protein with 
development to the blastocyst stage. Our 
results have demonstrated that when β1 
subunit siRNA microinjected 8-cell embryos 
are paired with either random sequence 
siRNA or uninjected controls they go on to 
form blastocysts in normal proportions, while 
those β1 subunit embryos which were paired 
together failed to develop to the blastocyst 
stage. This finding is consistent with our 
previous observation that down regulation of 
β1 subunit expression is associated with 
failure to support development to the 
blastocyst stage.  
More recently, a series of important 
studies primarily from Dr. Rajasekaran’s 
laboratory have demonstrated that the Na/K-
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ATPase also has roles in regulating cell 
motility, oncogenic transformation, epithelial 
to mesenchymal cell transition and tight 
junction formation and function (29-31,37). 
Madin Darby Canine Kidney cells (MDCK) 
transformed by Moloney virus (MSV-MDCK) 
express reduced levels of the Na/K-ATPase 
β1 subunit compared to non-transformed 
MDCK cells (31). When the Na/K-ATPase β1 
subunit levels are increased in MSV-MDCK 
cells one observes a corresponding increase in 
Na/K-ATPase α1 subunit protein due to 
enhanced α1 subunit translation (31). In 
addition, MSV-MDCK cells display a reduced 
cell motility (correlated with reduced Na/K-
ATPase β1 levels) that is overcome by also 
increasing Na/K-ATPase β1 subunit 
expression in these cells (32,34). Further 
studies have indicated that Na/K-ATPase β1 
subunit levels may be regulated by the 
transcription factor, “snail” as increased snail 
levels result in reduced Na/K-ATPase β1 
subunit levels and blockade of snail levels 
increased Na/K-ATPase β1 levels (37). 
Collectively these studies demonstrate that the 
Na/K-ATPase β1 subunit is a critical regulator 
of Na/K-ATPase α1 subunits and thus enzyme 
function and that Na/K-ATPase subunit levels 
are important mediators of the epithelial cell 
phenotype and cell motility. 
In addition, recent studies have also 
demonstrated that the Na/K-ATPase has an 
important role in regulating tight junction 
formation and function (32-35). Tight 
junctions are composed of several trans-
membrane proteins including Claudins and 
Occludin and several associated proteins 
including ZO-1, ZO-2, Cingulin, and 7H6 that 
link the junctional unit to the cell’s actin 
cytoskeleton (38-41). Inhibition of Na/K-
ATPase by ouabain treatment is associated 
with aberrant distribution of tight junction 
associated proteins and also tight junction 
function, as indicated by increased 
permeability to FITC labeled dextran 
molecules in both cell lines (32,34) and mouse 
blastocysts (17). We discovered that the 
disruption of ZO-1 tight junction protein 
distribution following ouabain treatment of 
early mouse embryos was correlated with re-
arrangements in Occludin distribution and 
these effects provided a basis for 
understanding the increased permeability to 
FITC-Dextran that ouabain treated embryo 
displayed (17). We have therefore concluded 
that Na+/K+-ATPase is a regulator of tight 
junction paracellular permeability in mouse 
blastocysts as well as epithelial cell lines. The 
outcomes from the present study also support 
this conclusion as we observed a dramatic 
shift in normal protein distribution for both 
ZO-1 and Occludin in all Na/K-ATPase β1 
subunit siRNA microinjected embryos. It is 
our expectation that the aberrant protein 
distribution patterns we observed in these 
embryos are indicative of a disrupted tight 
junction formation in Na/K-ATPase β1 
subunit siRNA microinjected embryos that 
would result in a failure in establishing a 
proper trophectoderm tight junction seal that 
is required to allow for expansion of the 
blastocyst cavity during cavitation. Thus the 
failure of Na/K-ATPase β1 subunit siRNA 
microinjected embryos to form blastocysts 
could have resulted from both a mis-targeting 
and proper insertion of Na/K-ATPase α 
subunits into the appropriate trophectoderm 
domains and also due to a disruption of tight 
junction assembly and establishment of the 
trophectoderm tight junctional seal. 
How might the Na/K-ATPase regulate 
tight junction formation? It seems likely that 
influences are mediated via regulation of the 
actin cytoskeleton. A model proposed by 
Barwe et. al., (29) suggests that the Na/K-
ATPase α subunit is able to phosphorylate 
p85 which recruits this subunit to the plasma 
membrane and results in activation of PI3 
kinase and the generation of PIP3 which 
induces the binding of annexin II to the Na/K-
ATPase β subunit cytoplasmic tail, activation 
of the Rac1 RhoGTPase and modifications to 
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the actin cytoskeleton. Studies have shown 
that loss of tight junction structure and 
increased paracellular permeability is often 
linked to the disruption of the circumferential 
actin ring that is localized at the apical pole of 
polarized epithelial cells (42-44).  In MDCK 
cells, loss of tight junction permeability upon 
Na+/K+-ATPase inhibition also is associated 
with reduced stress fiber content and reduced 
RhoA activity (34). Overexpression of  RhoA 
can bypass the inhibitory effect of Na+/K+-
ATPase inhibition on tight junction formation, 
indicating that RhoA is essential and may be 
downstream of Na+/K+-ATPase in regulating 
tight junction function (34). These 
possibilities certainly offer exciting directions 
to follow in our efforts to understand Na/K-
ATPase function during early development 
and in particular its role in regulating tight 
junction formation and function in the early 
embryo. 
In conclusion, blockade of Na/K-
ATPase β1 subunit expression by 
microinjection of Na/K-ATPase β1 siRNAs 
resulted in a failure of microinjected embryos 
to develop to the blastocyst stage which was 
associated with aberrant expression of Na/K-
ATPase α1 and tight junction ZO-1 and 
Occludin polypeptides indicating that the 
Na/K-ATPase β1 subunit is a potent regulator 
of both Na/K-ATPase α1 subunit membrane 
insertion and also tight junction protein 
assembly during preimplantation 
development. 
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FIGURE LEGENDS 
 
Fig. 1. Morphology of Na/K-ATPase β1 subunit siRNA microinjected embryos. Panel A, 
Morphological changes in mouse preimplantation development following Na/K-ATPase β1 
subunit siRNA microinjection into zygotes. Note a lack of complete blastocyst formation in 
Na/K-ATPase β1 subunit siRNA microinjected embryos, however a few (2.3%) of the embryos 
did have multiple and small blastocoel cavities (a). The group of embryos microinjected with 
control siRNA or those representing non-injected controls developed normally to the blastocyst 
stage (b and c). Panel B, The percentage of embryos that developed into blastocysts following 
Na/K-ATPase β1 subunit siRNA microinjection or control siRNA microinjection (CI) or non 
injected controls (C) are shown.  Only 2.3% of Na/K-ATPase β1 subunit siRNA injected zygotes 
progressed to the blastocyst stage compared to 73% (injected controls) or 91% (non injected 
controls). N= 3 independent experiments. Values with different symbols represent significant 
differences. P value = < 0.05. Panel C, Validation of Na/K-ATPase β1 siRNA efficacy at down 
regulating β1 gene expression. Transcripts encoding Na/K-ATPase β1 subunit were not detected 
in embryos injected with β1 siRNAs 4 days after microinjection. Embryos microinjected with 
control siRNA or non injected embryos displayed the appropriate Na/K-ATPase β1 mRNA 
product. Transcripts encoding β-actin were readily detected in all three treatment groups. The 
negative control represents no cDNA sample while the positive control is a mouse kidney cDNA 
sample. 
 
Fig. 2. Na/K-ATPase β1 subunit protein levels following microinjection of β1 siRNAs. The 
distribution of Na/K-ATPase β1 subunit polypeptides during murine preimplantation 
development was assessed (Panel e, f, g and h). Green, red and blue colors in each representative 
photomicrograph indicate positive staining for the respective primary antibody, F-actin 
(rhodamine phalloidin), and nuclei (DAPI) respectively. Panels a, b, c display a marked 
reduction in Na/K-ATPase β1 subunit fluorescence in embryos microinjected with β1 subunit 
siRNAs. Panel d shows the presence of multiple blastocoel cavities, which failed to coalesce to 
form a single blastocoel cavity in one of the rare (i.e. 2.3%) of Na/K-ATPase β1 siRNA injected 
zygotes that progressed to the blastocyst stage. 
  
Fig. 3. Distribution of Na/K-ATPase α1 subunit (a, b), ZO-1 (c, d) and Occludin (e, f) proteins in 
Na/K-ATPase β1 subunit siRNA microinjected embryos or control microinjected embryos. Note 
the discontinuous distribution of Na/K-ATPase α1 subunit in the Na/K-ATPase β1 subunit 
siRNA injected embryos. Loss of Na/K-ATPase β1 subunit also resulted in the shift from a 
“continuous” to “discontinuous” distribution for both ZO-1 and Occludin polypeptides. In 
addition both ZO-1 and Occludin immunofluorescence transitioned from a very tight focused 
signal adjacent to cell margins to become predominantly “discontinuous”and cytoplasmic in 
distribution. 
 
Fig. 4. Morphology of chimeric embryos. Panel A, Representative figures of chimeric embryos 
produced by pairing either β1 subunit deficient 8-cell embryos together (A:A), or to siRNA 
random sequence injected controls (A:B),  or to uninjected controls (A:C) or sequence siRNA 
injected controls together (B:B). While A:A embryos demonstrated a developmental blockade 
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following compaction, A:B, A:C and B:B embryos all progressed normally to the blastocyst 
stage. Panel B, The percentage of embryos that developed into blastocysts following 8-cell 
aggregation is shown. Values with different symbols represent significant differences. P value  < 
0.05.  
 
Fig. 5. Na/K-ATPase β1 subunit protein levels following chimera production. The distribution of 
Na/K-ATPase β1 subunit polypeptides was assessed between chimeric embryos produced by 
pairing either β1 subunit deficient 8-cell embryos together (A:A), or to siRNA random sequence 
injected controls (A:B),  or pairing random sequence siRNA injected controls together (B:B). 
Green, red and blue colors in each representative photomicrograph indicate positive staining for 
the respective primary antibody (Panels a, e and i) , F-actin (rhodamine phalloidin) (Panels b, f 
and j), and nuclei (DAPI) (Panels c, g and k) respectively. Panels d, h and l show a composite 
image of all three channels. 
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Table 1 Nucleotide sequences for polymerase chain reaction amplification reactions 
Gene Product Primer Primer sequence Size (bp) 
Na/K-ATPase β1 
subunit (5) 
5’ 
3’ 
TTCAGCCCAGAAGGACGACATG 
AGGGAAGCCGTAGTATCCGCCCA 
378 
β -actin 5’ 
3’ 
CGTGGGCCGCCCTAGGCACCA 
GGGGGGACTTGGGATTCCGGTT 
248 
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